Table 2.
Mechanisms of NETs Formation in the Context of Cancer
Mouse model | Detected NETs marker | NETs Formation Mechanism | Reference |
---|---|---|---|
Lewis lung carcinoma; Breast carcinoma; CML |
WB/IF: H3Cit; IF: DNA Plasma DNA Count; FACS: H3Cit+ Neutrophils |
Cancer cell-derived G-CSF | [41] |
Melonoma; Lewis lung carcinoma | WB/IF: H3Cit; IF: DNA | Cancer cell-derived G-CSF | [42] |
Colorectal cancer liver metastasis | IF: MPO+ /H3Cit+/extracellular DNA+ | Tumor-derived IL-8 | [43] |
Gall bladder cancer | IF: NE+ /H3Cit+/extracellular DNA+ | Cancer cell-derived IL-8 | [44] |
Lewis lung carcinoma; Breast carcinoma; Colon carcinoma |
IF: H3Cit+/extracellular DNA+ | Cancer cell-derived CXCR1 and CXCR2 ligands | [45] |
Lung metastasis of breast cancer | IF: MPO+ /H3Cit+/extracellular DNA+ | Cancer cell-derived Cathepsin C | [46] |
melanoma Pancreatic adenocarcinoma Lung adenocarcinoma |
IF: MPO+ /H3Cit+/extracellular DNA+ | Stroma-derived Amyloid β | [47] |
WB Western Blot, IF Immunofluorescence, H3Cit citrullinated histone H3, MPO myeloperoxidase, NE neutrophil elastase, CXCR CXC Chemokine Receptor